• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Carlyle Secured Lending, Inc. Announces Intent to Redeem All Outstanding 8.20% Notes Due 2028

    10/31/25 6:30:00 AM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services
    Finance
    Get the next $CG alert in real time by email

    NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (the "Company") (NASDAQ:CGBD) today announced that it intends to redeem all $85,000,000 aggregate principal amount of its outstanding 8.20% Notes due 2028 (the "2028 Notes") on December 1, 2025 (the "Redemption Date"). A notice of redemption will be mailed to all registered holders of the 2028 Notes by U.S. Bank Trust Company, National Association, as successor trustee to The Bank of New York Mellon Trust Company, N.A (the "Trustee"), in accordance with the terms of the Indenture, dated as of November 20, 2023 (the "Base Indenture"), between the Company and the Trustee, and the First Supplemental Indenture, dated as of November 20, 2023 (together with the Base Indenture, the "Indenture"). The redemption price for the 2028 Notes will equal 100% of the principal amount of the 2028 Notes being redeemed, plus accrued and unpaid interest otherwise payable for the then-current quarterly interest period accrued to, but excluding, the Redemption Date. In connection with the redemption, the 2028 Notes will be delisted from the Nasdaq Global Select Market (NASDAQ:CGBDL).

    This communication does not constitute a notice of redemption under the terms of the Indenture, nor an offer to tender for, or purchase, any 2028 Notes or any other security.

    About Carlyle Secured Lending: Carlyle Secured Lending, Inc. is a closed-end, non-diversified and externally managed investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. Our objective is to generate current income and capital appreciation by sourcing and providing senior secured debt investments to U.S. companies in the middle market that are generally backed by private equity sponsors. The Company is managed by Carlyle Global Credit Investment Management L.L.C., an SEC-registered investment adviser and a wholly owned subsidiary of Carlyle. We derive significant benefit from our ability access and leverage Carlyle's significant scale, vast resources and world-class talent.

    About Carlyle: Carlyle (NASDAQ:CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit, and Carlyle AlpInvest. With $474 billion of assets under management as of September 30, 2025, Carlyle's purpose is to invest wisely and create value on behalf of its investors, portfolio companies, and the communities in which we live and invest. Carlyle employs more than 2,400 people in 27 offices across four continents. Further information is available at www.carlyle.com. Follow Carlyle on X @OneCarlyle and LinkedIn at The Carlyle Group.

    Forward-Looking Statements

    Statements included herein contain certain "forward-looking statements" within the meaning of the federal securities laws, including statements with regard to the Company's redemption of the 2028 Notes. You can identify these statements by the use of forward-looking terminology such as "anticipates," "believes," "expects," "intends," "will," "should," "may," "plans," "continue," "believes," "seeks," "estimates," "would," "could," "targets," "projects," "outlook," "potential," "predicts" and variations of these words and similar expressions to identify forward-looking statements, although not all forward-looking statements include these words. You should not place undue reliance on these forward-looking statements, which speak only as of the date on which we make it. Completion of the transaction on the terms described above is subject to numerous conditions, many of which are beyond the control of the Company, and such transaction may not be completed on the terms described, or at all. Factors or events that could cause our actual results to differ, possibly materially from our expectations, include, but are not limited to, the risks, uncertainties and other factors we identify in the sections entitled "Risk Factors," "Supplementary Risk Factors" and "Special Note Regarding Forward-Looking Statements" in filings we make with the SEC, and it is not possible for us to predict or identify all of them. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

    Contacts: 
      
    Investors: Media:
    Nishil MehtaKristen Ashton
    +1 (212) 813-4918

    [email protected]
    +1 (212) 813-4763

    [email protected]





    Primary Logo

    Get the next $CG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CG
    $CGBD

    CompanyDatePrice TargetRatingAnalyst
    The Carlyle Group Inc.
    $CG
    12/11/2025$74.00Buy
    UBS
    Carlyle Secured Lending Inc.
    $CGBD
    12/8/2025Mkt Perform
    Citizens JMP
    Carlyle Secured Lending Inc.
    $CGBD
    10/7/2025$15.00Mkt Perform → Outperform
    Raymond James
    The Carlyle Group Inc.
    $CG
    10/3/2025$74.00Outperform
    BMO Capital Markets
    Carlyle Secured Lending Inc.
    $CGBD
    10/1/2025$12.50Underweight → Neutral
    Analyst
    Carlyle Secured Lending Inc.
    $CGBD
    7/25/2025$15.00Equal Weight → Overweight
    Wells Fargo
    Carlyle Secured Lending Inc.
    $CGBD
    7/17/2025Mkt Perform
    Raymond James
    The Carlyle Group Inc.
    $CG
    7/10/2025$65.00Neutral → Buy
    Citigroup
    More analyst ratings

    $CG
    $CGBD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Resonetics® Expands Bioelectronics Implant Offering with Acquisition of Manufacturing Assets and Process IP from Med-Ally

    NASHUA, N.H., Jan. 6, 2026 /PRNewswire/ -- Resonetics® announced today that it has acquired the manufacturing assets, process know-how, and intellectual property related to implantable and external pulse generators (IPG/EPG) and leads manufacturing and assembly from Med-Ally, a medical technology design and development company focused on the neuromodulation market and based in Charleston, South Carolina. The acquisition strengthens Resonetics' Medical Power business by combining its comprehensive implantable battery technologies with advanced pulse generator manufacturing proc

    1/6/26 8:00:00 AM ET
    $CG
    Investment Managers
    Finance

    Abingworth Announces Leadership Transition and Appointments

    Kurt von Emster transitions role of Head of Abingworth Life Sciences to Dr. Bali Muralidhar Travis Wilson joins as Managing Director across Abingworth and Carlyle, focusing on clinical co-development and life sciences buyout opportunities Kurt remains a Managing Partner of Abingworth focusing on clinical co-development investments and supporting venture investments while advancing Abingworth's strategic vision for growth January 5, 2026 – Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced several leadership changes. Kurt von Emster, Managing Partner and Head of Abingworth Life Sciences, is transitioning

    1/5/26 4:00:00 AM ET
    $CG
    Investment Managers
    Finance

    Vantage Group Holdings to be acquired by Howard Hughes Holdings

    Vantage's Diversified Specialty Insurance Platform Delivers Lower Risk and Superior Return Potential HHH to Host a Conference Call and Presentation on Thursday, December 18 at 8:30 a.m. ET, With an X Spaces Session to Follow HAMILTON, Bermuda, Dec. 18, 2025 /PRNewswire/ -- Vantage Group Holdings Ltd. ("Vantage"), a privately held leading specialty insurance and reinsurance company backed by Carlyle and Hellman & Friedman today announced that it has entered into a definitive agreement for Howard Hughes Holdings Inc. (NYSE:HHH) ("Howard Hughes," "HHH," or the "Company") to acquire 100% of Vantage for $2.1 billion in cash or approximately 1.5x year-end 2025 book value. The transaction is expect

    12/18/25 6:12:00 AM ET
    $CG
    $HHH
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    $CG
    $CGBD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Carlyle Group Inc. disposed of 6,815,617 units of Class B Common Stock, sold $554,953,657 worth of shares (19,136,333 units at $29.00), disposed of 1,549,243 shares and converted options into 6,815,617 shares (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    12/22/25 4:30:22 PM ET
    $CG
    Investment Managers
    Finance

    Chief Operating Officer Lobue Lindsay was granted 183,655 shares, increasing direct ownership by 39% to 660,500 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    12/19/25 7:48:27 PM ET
    $CG
    Investment Managers
    Finance

    Chief Financial Officer Redett John C. was granted 550,965 shares, increasing direct ownership by 50% to 1,651,081 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    12/19/25 7:48:18 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    $CGBD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO Hennigan Thomas M bought $101,136 worth of shares (8,400 units at $12.04), increasing direct ownership by 9% to 96,895 units (SEC Form 4)

    4 - Carlyle Secured Lending, Inc. (0001544206) (Issuer)

    11/17/25 4:10:29 PM ET
    $CGBD
    Finance: Consumer Services
    Finance

    PAO Joseph Nelson bought $17,760 worth of shares (1,500 units at $11.84) (SEC Form 4)

    4 - Carlyle Secured Lending, Inc. (0001544206) (Issuer)

    11/12/25 4:05:11 PM ET
    $CGBD
    Finance: Consumer Services
    Finance

    CFO Hennigan Thomas M bought $100,169 worth of shares (7,285 units at $13.75), increasing direct ownership by 9% to 88,495 units (SEC Form 4)

    4 - Carlyle Secured Lending, Inc. (0001544206) (Issuer)

    8/21/25 4:14:27 PM ET
    $CGBD
    Finance: Consumer Services
    Finance

    $CG
    $CGBD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS resumed coverage on Carlyle Group with a new price target

    UBS resumed coverage of Carlyle Group with a rating of Buy and set a new price target of $74.00

    12/11/25 9:06:22 AM ET
    $CG
    Investment Managers
    Finance

    Citizens JMP initiated coverage on Carlyle Secured Lending

    Citizens JMP initiated coverage of Carlyle Secured Lending with a rating of Mkt Perform

    12/8/25 8:33:41 AM ET
    $CGBD
    Finance: Consumer Services
    Finance

    Carlyle Secured Lending upgraded by Raymond James with a new price target

    Raymond James upgraded Carlyle Secured Lending from Mkt Perform to Outperform and set a new price target of $15.00

    10/7/25 8:46:03 AM ET
    $CGBD
    Finance: Consumer Services
    Finance

    $CG
    $CGBD
    SEC Filings

    View All

    The Carlyle Group Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    12/5/25 4:10:33 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 25-NSE filed by Carlyle Secured Lending Inc.

    25-NSE - Carlyle Secured Lending, Inc. (0001544206) (Subject)

    11/28/25 1:49:27 PM ET
    $CGBD
    Finance: Consumer Services
    Finance

    SEC Form 13F-HR filed by The Carlyle Group Inc.

    13F-HR - Carlyle Group Inc. (0001527166) (Filer)

    11/7/25 4:37:43 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    $CGBD
    Leadership Updates

    Live Leadership Updates

    View All

    Abingworth Announces Leadership Transition and Appointments

    Kurt von Emster transitions role of Head of Abingworth Life Sciences to Dr. Bali Muralidhar Travis Wilson joins as Managing Director across Abingworth and Carlyle, focusing on clinical co-development and life sciences buyout opportunities Kurt remains a Managing Partner of Abingworth focusing on clinical co-development investments and supporting venture investments while advancing Abingworth's strategic vision for growth January 5, 2026 – Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced several leadership changes. Kurt von Emster, Managing Partner and Head of Abingworth Life Sciences, is transitioning

    1/5/26 4:00:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints President and Chief Operations Officer Meghan Harris to Its Board of Directors

    MCLEAN, Va., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Meghan Harris, President and Chief Operations Officer (COO), to its board of directors. Harris brings over two decades of healthcare quality improvement, strategic operations, and client-focused innovation to the board. As President and COO, she oversees all public and commercial operations, solution development and quality, and contract implementations. "Meghan's appointment to the board reflects the significant impact of her strate

    12/17/25 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Names Patty Obermaier as Chief Growth Officer

    MCLEAN, Va., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced that former Microsoft executive Patty Obermaier has joined the company as Executive Vice President, Chief Growth Officer (CGO). In this role, Obermaier will lead the company's business development, marketing, and product management functions to bring innovative solutions to the healthcare industry's most pressing challenges. A distinguished executive with more than three decades of experience driving innovation, growth, and operational excellence across

    12/11/25 9:32:00 AM ET
    $ASGN
    $CG
    Professional Services
    Consumer Discretionary
    Investment Managers
    Finance

    $CG
    $CGBD
    Financials

    Live finance-specific insights

    View All

    Vantage Group Holdings to be acquired by Howard Hughes Holdings

    Vantage's Diversified Specialty Insurance Platform Delivers Lower Risk and Superior Return Potential HHH to Host a Conference Call and Presentation on Thursday, December 18 at 8:30 a.m. ET, With an X Spaces Session to Follow HAMILTON, Bermuda, Dec. 18, 2025 /PRNewswire/ -- Vantage Group Holdings Ltd. ("Vantage"), a privately held leading specialty insurance and reinsurance company backed by Carlyle and Hellman & Friedman today announced that it has entered into a definitive agreement for Howard Hughes Holdings Inc. (NYSE:HHH) ("Howard Hughes," "HHH," or the "Company") to acquire 100% of Vantage for $2.1 billion in cash or approximately 1.5x year-end 2025 book value. The transaction is expect

    12/18/25 6:12:00 AM ET
    $CG
    $HHH
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    ARMADA Acquires Poseidon Industrial LLC, Expanding Its Solutions Offering to the U.S. Navy and Defense Support Capabilities

    Strategic acquisition strengthens ARMADA's Fleet and enhances its ability to deliver preservation, modernization, and technical services across naval programs. ARMADA Parent Inc., a leading solutions provider for outsourced U.S. Navy ship repair and construction, today announced the acquisition of Poseidon Industrial LLC ("Poseidon"). Poseidon is a Virginia based company supporting the U.S. Navy and defense industry with mechanical, electrical, and systems integration services for modernization and repair projects. ARMADA, which is majority owned by Carlyle (NASDAQ:CG) and Stellex Capital Management, delivers integrated mission-critical solutions across its national footprint of operating

    11/12/25 1:00:00 PM ET
    $CG
    Investment Managers
    Finance

    Carlyle Secured Lending, Inc. Announces Financial Results For Third Quarter Ended September 30, 2025, Declares Fourth Quarter 2025 Dividend of $0.40 Per Common Share

    NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its third quarter ended September 30, 2025. Justin Plouffe, CGBD's Chief Executive Officer, said, "We continue to be active in the current market with disciplined underwriting standards. We experienced another quarter of net growth in the portfolio as we maintain leverage at the mid-point of our target range. On the other side of the balance sheet, we continued to optimize CGBD's capital structure post-quarter-end with our second institutional bond issuance and the repaymen

    11/4/25 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    $CG
    $CGBD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/15/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance